Service | Yield | Purification | Modifications | Deliverables | Turnaround Time |
---|---|---|---|---|---|
ASO Synthesis | R & D level: ug-mg | HPLC | PTO, 2′-F, 2′-OME, 2′-MOE, LNA, Cholesterol, GalNAc, etc. |
● Dry powder delivery, according to the customer needs of the separate packing. ● COA files. |
1 Week |
Manufacturing level: g | HPLC | PTO, 2′-F, 2′-OME, 2′-MOE, LNA, Cholesterol, GalNAc, etc. |
● Dry powder delivery, according to the customer needs of the separate packing. ● COA files. |
Inquire |
* If you need other special modifications or pricing, please contact us for a quote at quote@synbio-tech.com.
Chemical Modification | Common Name | Class of Modification | Activates RNase H1 | Binding Affinity Effects | Action |
---|---|---|---|---|---|
Phosphorothioate | PS | Backbone | Yes | Decreases | Binds non-specifically to proteins, exists as two stereoisomers |
2'-O-Methyl | 2'-OMe | Sugar | No | Increases | Natural RNA modification; decreases toxicity |
2'-O-Methoxyethyl | 2'-MOE | Sugar | No | Increases | Reduces protein binding, decreased toxicity |
Locked nucleic acids | LNA | Sugar | No | Increases | High binding affinity at the cost of increased toxicity |
5-Methylcytosine | 5-MedC | Base | Yes | Increases | Natural RNA modification; prevents activation of TLR9 in CpG motifs |
N-acetyl-galactosamine | GalNAc | Base | No | Decreases | Targets hepatocytes via receptor-mediated endocytosis |
2'-Fluoro | 2'-F | Sugar | No | Increases | Increases stability of RNA by preventing hydrolysis |
Cholesterol | Cholesterol |
Base (or non-nucleotide) |
No | Increases | Improves cellular uptake and stability of oligonucleotides |
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
To find out more about the cookies we use, see our Privacy Policy.